Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY crawled date : 2021 - 05 - 17 save search
Five ways to improve your business with Business Services
Published: 2021-05-17 (Crawled : 19:00) - modeln.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.22%
H: 0.1%
C: -0.26%
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19 Vaccine
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results vaccine covid-19
Positive Phase II Results Show There's Still Hope for the Sanofi/GSK COVID-19...
Published: 2021-05-17 (Crawled : 15:00) - biospace.com/
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid positive results covid-19
Phase 3 Data Presented at ATS 2021 Show REGEN-COV™ (casirivimab with imdevimab) Reduced Risk of Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Published: 2021-05-17 (Crawled : 14:15) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
covid risk casirivimab phase 3
Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., as President and Chief Medical Officer
Published: 2021-05-17 (Crawled : 14:15) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
eye
Pivotal data at ATS 2021 show Dupixent® (dupilumab) significantly reduced asthma attacks and improved lung function in children
Published: 2021-05-17 (Crawled : 14:15) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -0.03%
H: 1.84%
C: 1.41%
children dupixent
ESPERION Appoints Sheldon Koenig as President and CEO
Published: 2021-05-17 (Crawled : 13:15) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
ESPR | $1.83 -4.19% -4.37% 3.7M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -8.1%
ceo leo
AavantiBio Rounds Out Leadership Team with Appointment of Jessie Hanrahan, Ph.D. as Chief Regulatory Officer
Published: 2021-05-17 (Crawled : 12:00) - biospace.com/
BSX | $67.96 -0.24% 1.53% 6.2M
|
Health Technology
|
| O: -0.12%
H: 0.77%
C: 0.53%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
BLUE | $0.9668 -2.37% -2.43% 8.7M
|
Health Technology
|
| O: -1.06%
H: 2.33%
C: -0.3%
IBIO | $1.89 -3.08% 0.0% 270K
|
Health Technology
|
| O: -7.48%
H: 6.44%
C: 0.0%
Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial
Published: 2021-05-17 (Crawled : 06:00) - globenewswire.com
JNJ | News | $144.77 0.22% -0.01% 9.3M
|
Health Technology
|
| O: 0.11%
H: 0.87%
C: -0.01%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.59%
H: 1.0%
C: 0.83%
covid phase 2 vaccine trial response
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.